FDA Clearance Tracker · P040020-S049
ACRYSOF IQ RESTOR +3.0 D MULTIFOCAL TORIC INTRAOCULAR LENS
Last checked: Nov 20, 2026Latest source record: Dec 22, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Dec 22, 2016
Approved
Time to decision
1,231 days
Received Aug 9, 2013. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P040020-S049
- Device name
- ACRYSOF IQ RESTOR +3.0 D MULTIFOCAL TORIC INTRAOCULAR LENS
- Applicant
- Alcon Research, Ltd.
- Applicant location
- Fort Worth, TX
- Received
- Aug 9, 2013
- Decided
- Dec 22, 2016
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P040020
Device type
- Device type
- Lens, multifocal intraocular (MFK)
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for the AcrySof IQ ReSTOR +3.0 D Multifocal Toric Intraocular Lens. This device is indicated for primary implantation in the capsular bag of the eye for the visual correction of aphakia and pre-existing astigmatism secondary to removal of a cataractous lens in adult patients with and without presbyopia, who desire near, intermediate and distance vision, reduction of residual refractive cylinder and increased spectacle independence. The lens is intended to be placed in the capsular bag.
Source documents
Other decisions for Alcon Research, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- AcrySof IQ PanOptix Trifocal Intraocular Lens and AcrySof IQ PanOptix Toric Trifocal Intraocular LensPMA supplement
P040020-S087 · Decided Aug 26, 2019 · 207 days after receipt · Panel Track
Device type: Lens, multifocal intraocular (MFK) · Ophthalmology
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.